,23 Loss or decreased expression of CDX2 is a common event in CRC, being associated with molecular features, such as CpG island methylator phenotype, and microsatellite instability24 and may be predictive of a more aggressive disease course.22 Here, CDX2 is linked to colorectal carcinoma.